DRIVIN G ROWTH - Dr. Reddy's

118
schedules to the balance sheet |
(All amounts in Indian Rupees thousands, except share data)
As at As at
March 31, 2002 March 31, 2001
schedule 12: provisions
Current taxes (net of advance tax) – 17,019
Proposed dividend 191,290 126,355
Tax on proposed dividend
Provision for
– 12,888
Gratuity 38,164 50,076
Leave encashment 50,830 30,908
280,284 237,246
schedule 13: miscellaneous expenditure
(to the extent not written-off or adjusted)
Share issue expenses
Balance at the beginning of the year
Add:Additions during the year
2,507 –
ADS issue – 2,007
Public issue (addition due to amalgamation) – 500
2,507 2,507
Less: Adjusted against share premium account (2,007) –
Less: Written-off during the year (500) –
Development expenditure
Contributions to Dr. Reddy’s Research Foundation
– 2,507
Balance at the beginning of the year 536,410 465,513
Add:Additions during the year – 205,000
536,410 670,513
Less: Written-off during the year (536,410) (134,103)
Contribution to Reddy US Therapeutics Inc.
– 536,410
Balance at the beginning of the year 50,146 –
Add:Additions during the year – 62,682
50,146 62,682
Less: Written-off during the year (50,146) (12,536)
Product development expenditure
– 50,146
Balance at the beginning of the year 338,727 267,251
Add: Additions during the year – 155,660
338,727 422,911
Less: Written-off during the year (338,727) (84,184)
Market development expenditure
– 338,727
Balance at the beginning of the year 17,819 73,344
Add: Additions during the year – –
17,819 73,344
Less: Amount amortised during the year (11,748) (55,525)
Less: Written-off during the year (6,071) –
– 17,819
– 945,609
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002